SS
Samantha Semenkow Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $123 |
45%
upside
| 1 | +11% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $52 |
181%
upside
| 1 | +70% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $46 |
31%
upside
| 1 | +0.32% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $35 |
33%
upside
| 1 | +5.9% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $14 |
192%
upside
| 1 | +19% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Buy
Initiated
| $33 |
119%
upside
| 1 | +21% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $35 |
17%
upside
| 1 | +26% |
0
%
| 10 Feb ‘26 2 months ago |
|